Local News

Seattle-based Icosavax has filed to go public via an IPO, just four years after it launched out…

An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the…

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases today announced the…

Neoadjuvant immune checkpoint blockade (ICB) is a promising treatment for melanoma and other cancer types,…

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development…

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments…

Edward Holland, MD, has been named chief medical advisor of Aurion Biotech, whose mission is…

BBI: What is the focus of your work? How does it relate to BBI’s focus…

A change of instructions in a computer program directs the computer to execute a different…

In a cross-country collaboration that began a decade ago, cancer researchers have now found that…